newsfilter
← Latest News
GlobeNewswire·

Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan

SALT LAKE CITY, April 14, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics Inc., (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Japan's Ministry of Health, Labour and